IPV LIMITED

Company number 05168019 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: IPV LIMITED

1. Financial Health Score: B- (Provisional)

Note: Without access to detailed profit and loss or balance sheet figures, this score is based on corporate vital signs, compliance metrics, and governance indicators. The score reflects a business with a strong administrative pulse but showing concerning symptoms of governance instability and structural anomalies.


2. Key Vital Signs

  • Pulse (Filing Compliance): Strong and Steady. The company’s accounts and confirmation statements are up to date, with the next accounts due in September 2026. This indicates a healthy administrative function; the company is breathing on its own and meeting its statutory respiratory requirements.
  • Blood Pressure (Corporate Capital): Dangerously Low. The issued share capital stands at a mere £190.70. For a 20-year-old technology company, this is an exceptionally lean equity base. It suggests the business is either heavily reliant on debt financing, operating on accumulated retained earnings, or functioning as a subsidiary funded by a parent company.
  • Immune System (Governance & Stability): Showing Symptoms of Distress. A cluster of three director resignations occurred within a very tight timeframe in mid-2026 (May and June). While boardroom turnover is normal, an acute cluster like this is a classic symptom of underlying corporate restructuring, a shift in strategic direction, or internal friction.
  • Genetic Makeup (Business Identity): Mutated. The registered SIC code (26309) classifies the company under the "Manufacture of communication equipment." However, the operational reality—derived from the company's website—reveals IPV is a software/SaaS company providing a "world-leading video asset management platform." The company has evolved, but its statutory DNA has not been updated to reflect its current operating model.

3. Diagnosis

The patient is a mature entity (incorporated in 2004) that has successfully navigated the market for two decades, which is a positive indicator of underlying business resilience. However, the current diagnostic data reveals a complex corporate physiology.

The most glaring symptom is the opacity of ownership combined with the low share capital. The PSC (People with Significant Control) register contains only a statutory statement rather than naming a specific individual or corporate entity. In a UK private company, this usually indicates that the true control lies with a parent overseas entity or a corporate group structure that is still finalizing its PSC registration. This aligns with the low share capital; IPV LIMITED is likely a subsidiary functioning as a cost center or a localized sales arm for a larger global group, rather than a standalone venture capital-backed startup.

The recent director exodus is a localized infection that requires monitoring. When multiple directors leave simultaneously, it often precedes a change in ownership, a strategic pivot, or a merger. The remaining leadership team, including a specialized Finance Director (Mike Feely), will need to ensure the company maintains its strategic direction during this transition.

Finally, the outdated SIC code is a benign cyst. It does not harm the company's day-to-day operations, but it does create a false statutory identity. For a company boasting a "world-leading" tech platform, being officially classified as a manufacturer of telegraph equipment is a regulatory anachronism.


4. Recommendations

To improve its financial wellness and corporate hygiene, IPV LIMITED should undertake the following treatment plan:

  1. Update Corporate DNA: File a confirmation statement to update the SIC code from manufacturing (26309) to a more accurate classification, such as 62090 (Other information technology service activities) or 63110 (Data processing, hosting and related activities). This ensures statutory records accurately reflect the company's true operational health.
  2. Governance Health Check: Conduct an internal review to ensure the recent board departures have not left the company vulnerable in terms of quorum, signing authority, or operational knowledge. Ensure the remaining directors are not overburdened with compliance duties.
  3. Improve Ownership Transparency: Resolve the PSC register anomaly. If the company is owned by a larger corporate group, this should be formally documented and filed to provide transparency to creditors, partners, and regulators.
  4. Capital Review: If the company is trading profitably, consider whether a capitalization of retained earnings is necessary. Operating with less than £200 in share capital while managing a global tech platform is legally fine, but it can sometimes raise red flags for credit agencies or potential partners assessing the company's financial bedrock.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 25 August 2026